CNBC Options Action June 2, 2017
Name . Well tell you which one. The action begins right now. That doubles every day, particularly bad. Biotech stocks posted their best in more than a month. The biotech, the ibb rallying more than 3 this week. It comes as the group lacked to the broader nasdaq 100. So is biotech finally playing catch up to the market . Should you buy in . Yeah, well, i definitely think so. Look, we did see some bullish activity in the biotech etf earlier this week. Looking for a 15 gain in there. Probably by about september. There are a lot of reasons why you might think there is room for a rally. For one thi...